Prognostic Value of CD166 Expression in Cancers of the Digestive System: A Systematic Review and Meta-Analysis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Ni, Chao ^a   Zhang, Zhigang ^a   Zhu, Xiaotao ^a   Liu, Yang ^a   Qu, Dihong ^a   Wu, Ping ^a   Huang, Jian ^a,b   Xu, A xiang ^c  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE;

ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL FEATURE; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE MARKER; ESOPHAGUS CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PANCREAS CANCER; PROTEIN EXPRESSION; STOMACH CANCER; SYSTEMATIC REVIEW; TUMOR VOLUME;

EID: 84881098356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070958     Document Type: Article

References (46)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
3. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105: 13427-13432.
4. Levin TG, Powell AE, Davies PS, Silk AD, Dismuke AD, et al. (2010) Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology 139: 2072-2082 e2075.
5. Jiao J, Hindoyan A, Wang S, Tran LM, Goldstein AS, et al. (2012) Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLoS One 7: e42564.
6. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, et al. (1995) Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181: 2213-2220.
7. Hansen A SG, Zijlstra A. (2011) ALCAM. doi:101038/mpa00412601.
8. Weichert W, Knosel T, Bellach J, Dietel M, Kristiansen G, (2004) ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57: 1160-1164.
9. Horst D, Kriegl L, Engel J, Kirchner T, Jung A, (2009) Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest 27: 844-850.
10. Lugli A, Iezzi G, Hostettler I, Muraro MG, Mele V, et al. (2010) Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 103: 382-390.
11. Tachezy M, Zander H, Gebauer F, Marx A, Kaifi JT, et al. (2012) Activated leukocyte cell adhesion molecule (CD166)-its prognostic power for colorectal cancer patients. J Surg Res 177: e15-20.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
13. Patel BB, Yu Y, Du J, Levi E, Phillip PA, et al. (2009) Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer. Biochem Biophys Res Commun 378: 344-347.
14. Tachezy M, Zander H, Marx AH, Gebauer F, Rawnaq T, et al. (2011) ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients. J Surg Res 170: 226-232.
15. Hong X, Michalski CW, Kong B, Zhang W, Raggi MC, et al. (2010) ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer. J Surg Oncol 101: 564-569.
16. Leavell BJ, Van Buren E, Antaki F, Axelrod BN, Rambus MA, et al. (2012) Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups. Dig Dis Sci 57: 2334-2339.
17. Sarkar D, Shields B, Davies ML, Muller J, Wakeman JA, (2012) BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells. Int J Cancer 130: 328-337.
18. Melin C, Perraud A, Akil H, Jauberteau MO, Cardot P, et al. (2012) Cancer stem cell sorting from colorectal cancer cell lines by sedimentation field flow fractionation. Anal Chem 84: 1549-1556.
19. Muraro MG, Mele V, Daster S, Han J, Heberer M, et al. (2012) CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Stem Cells Transl Med 1: 592-603.
20. Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, et al. (2011) Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res 17: 6934-6943.
21. Hansen AG, Freeman TJ, Arnold SA, Starchenko A, Jones-Paris CR, et al. (2013) Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome. Cancer Res.
22. Borlak J, Meier T, Halter R, Spanel R, Spanel-Borowski K, (2005) Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene 24: 1809-1819.
23. Verma A, Shukla NK, Deo SV, Gupta SD, Ralhan R, (2005) MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology 68: 462-470.
24. Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, et al. (2011) MicroRNA-192 and-215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 30: 1577-1585.
25. Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, et al. (2009) Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics Proteomics 6: 19-29.
26. Varghese S, Burness M, Xu H, Beresnev T, Pingpank J, et al. (2007) Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann Surg Oncol 14: 3460-3471.
27. Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, et al. (2011) SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 141: 279-291, 291 e271-275.
28. Lee HJ, Eom DW, Kang GH, Han SH, Cheon GJ, et al. (2012) Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells. Mod Pathol.
29. Tachezy M, Effenberger K, Zander H, Minner S, Gebauer F, et al. (2012) ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients. Int J Cancer 131: 396-405.
30. Ishigami S, Ueno S, Arigami T, Arima H, Uchikado Y, et al. (2011) Clinical implication of CD166 expression in gastric cancer. J Surg Oncol 103: 57-61.
31. Kahlert C, Weber H, Mogler C, Bergmann F, Schirmacher P, et al. (2009) Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br J Cancer 101: 457-464.
32. Todaro M, Francipane MG, Medema JP, Stassi G, (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151-2162.
33. Chen T, Yang K, Yu J, Meng W, Yuan D, et al. (2012) Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res 22: 248-258.
34. Lonardo E, Hermann PC, Mueller MT, Huber S, Balic A, et al. (2011) Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 9: 433-446.
35. Chen Y, Li D, Wang D, Liu X, Yin N, et al. (2012) Quiescence and attenuated DNA damage response promote survival of esophageal cancer stem cells. J Cell Biochem 113: 3643-3652.
36. Tachezy M, Zander H, Marx AH, Stahl PR, Gebauer F, et al. (2012) ALCAM (CD166) expression and serum levels in pancreatic cancer. PLoS One 7: e39018.
37. van den Brand M, Takes RP, Blokpoel-deRuyter M, Slootweg PJ, van Kempen LC, (2010) Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma. Oral Oncol 46: 393-398.
38. Mezzanzanica D, Fabbi M, Bagnoli M, Staurengo S, Losa M, et al. (2008) Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clin Cancer Res 14: 1726-1733.
39. Burkhardt M, Mayordomo E, Winzer KJ, Fritzsche F, Gansukh T, et al. (2006) Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59: 403-409.
40. van Kempen LC, Nelissen JM, Degen WG, Torensma R, Weidle UH, et al. (2001) Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276: 25783-25790.
41. Bech-Serra JJ, Santiago-Josefat B, Esselens C, Saftig P, Baselga J, et al. (2006) Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol Cell Biol 26: 5086-5095.
42. Piazza T, Cha E, Bongarzone I, Canevari S, Bolognesi A, et al. (2005) Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. J Cell Sci 118: 1515-1525.
43. Rosso O, Piazza T, Bongarzone I, Rossello A, Mezzanzanica D, et al. (2007) The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. Mol Cancer Res 5: 1246-1253.
44. van Kempen LC, Meier F, Egeblad M, Kersten-Niessen MJ, Garbe C, et al. (2004) Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis. J Invest Dermatol 122: 1293-1301.
45. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, et al. (2012) Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas. Science.
46. Kulasingam V, Zheng Y, Soosaipillai A, Leon AE, Gion M, et al. (2009) Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer. Int J Cancer 125: 9-14.